FBDIX vs. GILD

Last updated Apr 2, 2026

Compare and contrast key facts about Franklin Biotechnology Discovery Fund (FBDIX) and Gilead Sciences, Inc. (GILD).

FBDIX is managed by Franklin Templeton. It was launched on Sep 14, 1997.

Performance

FBDIX vs. GILD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Franklin Biotechnology Discovery Fund (FBDIX) and Gilead Sciences, Inc. (GILD). The values are adjusted to include any dividend payments, if applicable.

FBDIX vs. GILD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FBDIX Franklin Biotechnology Discovery Fund	2.34%	52.68%	15.37%	18.40%	-12.65%	-27.58%	29.85%	49.11%	-15.77%	18.83%
GILD Gilead Sciences, Inc.	14.96%	36.59%	18.68%	-1.99%	23.63%	29.95%	-6.70%	7.88%	-9.92%	2.96%

Returns By Period

In the year-to-date period, FBDIX achieves a 2.34% return, which is significantly lower than GILD's 14.96% return. Over the past 10 years, FBDIX has outperformed GILD with an annualized return of 10.84%, while GILD has yielded a comparatively lower 7.81% annualized return.

FBDIX

• 1D: 5.83%
• 1M: -0.40%
• YTD: 2.34%
• 6M: 25.15%
• 1Y: 69.79%
• 3Y*: 28.39%
• 5Y*: 7.17%
• 10Y*: 10.84%

GILD

• 1D: 0.67%
• 1M: -5.95%
• YTD: 14.96%
• 6M: 27.78%
• 1Y: 29.43%
• 3Y*: 23.25%
• 5Y*: 20.53%
• 10Y*: 7.81%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

FBDIX vs. GILD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FBDIX

FBDIX Risk / Return Rank: 95
FBDIX Sharpe Ratio Rank: 96
FBDIX Sortino Ratio Rank: 95
FBDIX Omega Ratio Rank: 89
FBDIX Calmar Ratio Rank: 97
FBDIX Martin Ratio Rank: 97

GILD

GILD Risk / Return Rank: 73
GILD Sharpe Ratio Rank: 74
GILD Sortino Ratio Rank: 70
GILD Omega Ratio Rank: 64
GILD Calmar Ratio Rank: 77
GILD Martin Ratio Rank: 78

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FBDIX vs. GILD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Franklin Biotechnology Discovery Fund (FBDIX) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FBDIX	GILD	Difference
Sharpe ratio Return per unit of total volatility	2.47	1.02	+1.45
Sortino ratio Return per unit of downside risk	3.14	1.63	+1.51
Omega ratio Gain probability vs. loss probability	1.40	1.19	+0.21
Calmar ratio Return relative to maximum drawdown	4.35	2.07	+2.28
Martin ratio Return relative to average drawdown	17.17	5.62	+11.55
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FBDIX vs. GILD - Sharpe Ratio Comparison

The current FBDIX Sharpe Ratio is 2.47, which is higher than the GILD Sharpe Ratio of 1.02. The chart below compares the historical Sharpe Ratios of FBDIX and GILD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	FBDIX	GILD	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.47	1.02	+1.45
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.28	0.86	-0.58
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.41	0.31	+0.11
Sharpe Ratio (All Time) Calculated using the full available price history	0.41	0.39	+0.01

Correlation

The correlation between FBDIX and GILD is 0.60, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

FBDIX vs. GILD - Dividend Comparison

FBDIX's dividend yield for the trailing twelve months is around 10.56%, more than GILD's 2.27% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FBDIX Franklin Biotechnology Discovery Fund	10.56%	10.81%	19.53%	0.00%	0.13%	0.98%	14.50%	18.77%	3.72%	2.39%	4.57%	8.42%
GILD Gilead Sciences, Inc.	2.27%	2.57%	3.33%	3.70%	3.40%	3.91%	4.67%	3.88%	3.65%	2.90%	2.57%	1.27%

Drawdowns

FBDIX vs. GILD - Drawdown Comparison

The maximum FBDIX drawdown since its inception was -71.44%, roughly equal to the maximum GILD drawdown of -70.83%. Use the drawdown chart below to compare losses from any high point for FBDIX and GILD.

Drawdown Indicators

	FBDIX	GILD	Difference
Max Drawdown Largest peak-to-trough decline	-71.44%	-70.83%	-0.61%
Max Drawdown (1Y) Largest decline over 1 year	-12.39%	-13.77%	+1.38%
Max Drawdown (5Y) Largest decline over 5 years	-46.83%	-26.59%	-20.24%
Max Drawdown (10Y) Largest decline over 10 years	-53.67%	-36.01%	-17.66%
Current Drawdown Current decline from peak	-1.98%	-9.44%	+7.46%
Average Drawdown Average peak-to-trough decline	-28.90%	-22.20%	-6.70%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.44%	5.08%	-1.64%

Volatility

FBDIX vs. GILD - Volatility Comparison

Franklin Biotechnology Discovery Fund (FBDIX) has a higher volatility of 9.67% compared to Gilead Sciences, Inc. (GILD) at 6.36%. This indicates that FBDIX's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FBDIX	GILD	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.67%	6.36%	+3.31%
Volatility (6M) Calculated over the trailing 6-month period	16.55%	18.91%	-2.36%
Volatility (1Y) Calculated over the trailing 1-year period	26.07%	29.01%	-2.94%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	25.57%	23.90%	+1.67%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	26.40%	25.63%	+0.77%